Anti-CLEC9A [8F9]

Recognises human DNGR-1, also known as CLEC9A, which is a highly specific marker of a human DC subset, as well as a receptor able to recognise a preformed signal exposed on necrotic cells.

Contributors

Institute
Cancer Research UK, London Research Institute: Lincoln's Inn Fields
Cat. #: 151707
Tool sub type: Primary antibody
Unit size: 100 ug
Research Fields: Immunology;Stem cell biology
Application: FACS ; IHC ; FACS ; IF
Target: Human DNGR1
Reactivity: Human
Clone: 8F9
Host: Mouse
Class: Monoclonal
Product description: Recognises human DNGR-1, also known as CLEC9A, which is a highly specific marker of a human DC subset, as well as a receptor able to recognise a preformed signal exposed on necrotic cells.
Conjugation: Unconjugated
Isotype: IgG2a
Immunogen: RBL-2H3 cells expressing human DNGR-1 fused to an HA epitope
Myeloma used: Sp2/0-Ag14
Target background: Recognises human DNGR-1, also known as CLEC9A, which is a highly specific marker of a human DC subset, as well as a receptor able to recognise a preformed signal exposed on necrotic cells.
Format: Liquid
Concentration: 1 mg/ml
Storage buffer: PBS with 0.02% azide
Storage conditions: -15° C to -25° C
Shipping conditions: Dry ice
References:

Poulin et al. 2010. J Exp Med. 207:1261-71. [PMID: 20479117]

Sancho et al. 2008. J Clin Invest 118:2098-110 .[PMID: 18497879]

Sancho et al. 2009. Nature. 458:899-903. [PMID: 19219027]

Canavan et al. 2018. JCI Insight. 3(23):. PMID: 30518680.

Images

View Gallery
Adapted from Canavan et al. 2018. JCI Insight; 3(23). PMID

Related Tools for Antibodies

Cat. # Tool Name
151022 Anti-IL12 [1-1A4] Key Info View Tool
151024 Anti-Hairy [1/24] Key Info View Tool
151027 Anti-HSVICP8 [10A3] Key Info View Tool
151017 Anti-MBP [R29.6] Key Info View Tool
151028 Anti-Cytochrome P450 2C2, 2B1/2 [h7] Key Info View Tool

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.